UHPLC–MS-MS Determination of THC, CBD and Their Metabolites in Whole Blood of Light Cannabis Smokers
Journal of Analytical Toxicology · 2023
DOI: 10.1093/jat/bkac081 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Analytical Toxicology, 2023. Verfasst von Alfredo Fabrizio Lo Faro und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Excellence of Biomedical Sciences and Public Health, Section of Legal Medicine, Unit of Forensic Toxicology, Via Tronto 10A, Ancona, To…. Hauptthemen laut MEDLINE: Cannabidiol, Cannabis, Hallucinogens. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 18 Literaturangaben. Gefördert von: Italian Department of Antidrug Policies.
Abstract (Originalsprache)
“Light cannabis” is a product legally sold in Europe with Δ9-tetrahydrocannabinol (THC) concentration <0.2% and variable cannabidiol (CBD) content. In this study, we aimed to assess the time courses of THC and metabolites (11-nor-9-carboxy-THC and 11-hydroxy-THC) and CBD and metabolites (CBD-7-oic acid, 7-hydroxy-CBD, 6α-hydroxy-CBD and 6β-hydroxy-CBD) in whole blood of 10 healthy participants after smoking one or four light cannabis cigarettes (0.16% THC and 5.8% CBD). Blood samples were collected 0.5–4 h after administration. Blood analysis was performed by reversed-phase ultra-performance liquid chromatography–tandem mass spectrometry in multiple reaction monitoring mode after glucuronide hydrolysis and liquid–liquid extraction in basic and acidic conditions. The method was validated following the most recent guidelines in toxicology: the method was linear, accurate, precise and sensitive (lower limits of quantification ranged from 0.005 to 0.01 ng/mL); carryover, matrix effect, recovery, process efficiency and dilution integrity were also assessed. As previously reported, the main metabolites of THC were THC-COOH and then 11-OH-THC, and the main metabolites of CBD were 7-OH-CBD and then 7-COOH-CBD. The time of the first collection, which likely occurred after the maximal concentration of most of the analytes, and the short monitoring time, up to 4 h after smoking, limited the evaluation of the pharmacokinetic parameters.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Excellence of Biomedical Sciences and Public Health, Section of Legal Medicine, Unit of Forensic Toxicology, Via Tronto 10A, Ancona, Torrette Ancona (AN) 60126, Italy.
- Comedical s.r.l., Via della Cooperazione 29, Trento (TN) 28123, Italy.
- National Centre on Addiction and Doping, Istituto Superiore di Sanità, Viale Regina Elena 299, Rome 00161, Italy.
ORCID-Profile: Simona Pichini, Jeremy Carlier
Förderung
- Italian Department of Antidrug Policies
Zitieren
APA
Lo Faro, A. F., Tini, A., Gottardi, J., Pichini, S., Carlier, J., Giorgetti, R., & Busardò, F. P. (2023). UHPLC–MS-MS Determination of THC, CBD and Their Metabolites in Whole Blood of Light Cannabis Smokers. Journal of Analytical Toxicology. https://doi.org/10.1093/jat/bkac081
Vancouver
Lo Faro AF, Tini A, Gottardi J, Pichini S, Carlier J, Giorgetti R, et al. UHPLC–MS-MS Determination of THC, CBD and Their Metabolites in Whole Blood of Light Cannabis Smokers. Journal of Analytical Toxicology. 2023. doi:10.1093/jat/bkac081
BibTeX
@article{LoFaro2023,
author = {Lo Faro, Alfredo Fabrizio and Tini, Anastasio and Gottardi, Josué and Pichini, Simona and Carlier, Jeremy and Giorgetti, Raffaele and Busardò, Francesco Paolo},
title = {UHPLC–MS-MS Determination of THC, CBD and Their Metabolites in Whole Blood of Light Cannabis Smokers},
journal = {Journal of Analytical Toxicology},
year = {2023},
doi = {10.1093/jat/bkac081}
}
EUVIMED